StephenOngMD
Family Medicine • Oxon Hill, MDMedical Director, Healthcare of Greater Washington and Research Director, MD Medical Research
Dr. Ong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6357 Oxon Hill Rd
Oxon Hill, MD 20745Phone+1 301-839-2700Fax+1 301-839-1354
Education & Training
University of MarylandResidency, Obstetrics and Gynecology, 1973 - 1974
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1972 - 1972
Loma Linda University Health Education ConsortiumFellowship, Health Administration, 1970 - 1971
Loma Linda UniversityMPH, 1971- University of the East College of MedicineClass of 1970
- Philippine Union CollegeBS, 1965
Certifications & Licensure
CA State Medical License 1976 - Present
VA State Medical License 1979 - 2026
MD State Medical License 1973 - 2025
DC State Medical License 1973 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012
Clinical Trials
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 11 citationsIntervention versus a conservative approach in the management of TRAP sequence: a systematic reviewFionnuala Mone, Priscilla Devaseelan, Stephen Ong
Journal of Perinatal Medicine. 2016-08-01 - 60 citationsClinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart A...Michael H. Alderman, Linda B. Piller, Charles E. Ford, Jeffrey L. Probstfield, Suzanne Oparil
Hypertension. 2012-05-01 - 36 citationsMortality and Morbidity During and After the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C. Cushman, Barry R. Davis, Sara L. Pressel, Jeffrey A. Cutler, Paula T. Einhorn
Journal of Clinical Hypertension. 2012-01-01
Journal Articles
- Platelet inhibition beyond conventional antiplatelet agents: expanding role of Angiotensin receptor blockers, stations and selective serotonin reuptake inhibitors.Stephen Ong, Int J Clin Pract, August 2006, 60, 8, 993-1002
Abstracts/Posters
- Do Clinical Trials Translate into Clinical Experience?Stephen Ong, MAFP 2003 Annual Assembly
- Risk and Impact of Incident Glucose Disorders in Hypertensive Older Adults Treated with an Ace Inhibitor, a Diuretic, or a Calcium Channel Blocker: A Report from the A...Stephen Ong, American Society of Hypertension, New York, NY
Lectures
- Hypercholesterolemia.
- Physician Practice Management.
- Angiotensin II Receptor Blockers: New and Different.
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
